Company / EPS (Diluted)
InspireMD, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.76
FY2025
5-year range
-$6.97 / -$0.76
FY2021-FY2025
Trend
+7.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has increased for 3 consecutive years, from $-6.97 in FY2021 to $-0.76 in FY2025.
Based on SEC 10-K filings.
-0.76 in FY2025.
Improved from $-2.35 to $-0.76 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 7.3% year-over-year.
- Lowest eps (diluted) in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.76 | +7.3% |
| FY2024 | -$0.82 | +65.1% |
| FY2023 | -$2.35 | - |
| FY2022 | - | - |
| FY2021 | -$6.97 | -45.2% |
| FY2020 | -$4.80 | +71.2% |
| FY2019 | -$16.67 | +52.3% |
| FY2018 | -$34.98 | +83.2% |
| FY2017 | -$207.72 | -271.9% |
| FY2016 | -$55.85 | -687.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026